The race for a Covid-19 vaccine has begun as the U.K and U.S have already started working on the first batches of vaccine trials. But the rest of the world is not far behind in vaccine research either as earlier this week South Africa’s health minister Zweli Mkhize pronounced that the country’s participation in the Public Health Emergency Solidarity Trial created by the World Health Organisation. Mkhize stated that participation in the trials benefit South Africa from being at the forefront of accessing approved vaccines and adding our expertise to the global body of knowledge around Covid-19. Shabir Madhi, Professor of Vaccinology at the University of Witwatersrand joins CNBC Africa for more.
South Africa’s Health Minister Zweli Mkhize said on Monday that the number of confirmed coronavirus cases had risen to 402, a jump of 128 since Sunday’s announcement that could worry public health experts concerned about the country’s readiness to deal with the epidemic.
With South Africa’s Health Minister Zweli Mkhize warning that between 60 to 70 per cent of South Africans will contract Covid-19 - a fraction of which will have serious cases, what are private sector health companies doing? RH Bophelo CEO, Quinton Zungu joins CNBC Africa for more.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.